Refractory short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing responsive to anti-calcitonin gene-related peptide monoclonal antibodies: A case report.
Cephalalgia
; 41(1): 127-130, 2021 01.
Article
em En
| MEDLINE
| ID: mdl-32867531
ABSTRACT
BACKGROUND:
Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) is a rare but severely disabling variant within the spectrum of trigeminal autonomic cephalalgia lacking evidence-based treatment. CASE We report a case of chronic SUNCT in a 67-year-old man refractory to various guideline-conforming treatment attempts responding excellently to galcanezumab.CONCLUSIONS:
This case report indicates that monoclonal antibodies against calcitonin gene-related peptide, specifically galcanezumab, might be a treatment option for SUNCT warranting further investigation.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Transtornos da Cefaleia
/
Síndrome SUNCT
/
Neuralgia
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article